Topic
Filter News
Found 767,889 articles
-
Long, Low Intensity Exercise May Have More Health Benefits Relative to Short, Intense Workouts, Maastricht University Study
2/15/2013
-
FDAAdvisoryCommittee.com Grants Orphan Drug Status to Eisai Inc.'s Lenvatinib
2/15/2013
-
Dako A/S (Acquired by Agilent Technologies, Inc.) Receives FDA Approval for Fast, Accurate, Nontoxic FISH Assay for Cancer Diagnostics
2/15/2013
-
Taste Preferences Impact Health, University of North Carolina Study
2/15/2013
-
IBA Molecular Announces Submittal of ANDA for Ammonia N 13 Injection
2/15/2013
-
Medical Imaging Drugs Advisory Committee Recommends Approval of Guerbet NDA for Dotarem® (gadoterate meglumine)
2/15/2013
-
Algeta: Further Sub-Analyses of ALSYMPCA Phase III Study Presented at 2013 Genitourinary Cancers Symposium
2/15/2013
-
Amicus Therapeutics, Inc. Presents Additional 6-Month Results From Phase 3 Fabry Monotherapy Study at LDN World Symposium
2/15/2013
-
rEVO Biologics Release: ATryn Antithrombin (Recombinant) Prevents Venous Thromboembolic Events in Pregnant Patients With Hereditary Antithrombin Deficiency
2/15/2013
-
Northwest Biotherapeutics Takes Next Steps in Moving Forward With Its Phase III Brain Cancer Trial in Europe
2/15/2013
-
Argos Therapeutics, Inc. Announces Updated Phase 2 Data for AGS-003 Personalized Immunotherapy for Metastatic Renal Cell Carcinoma
2/15/2013
-
Clasado Announces Positive Results of Clinical Study of Bimuno® for Metabolic Syndrome
2/15/2013
-
Gamida Cell Ltd.'s NiCord® Demonstrates Successful Engraftment in Patients With Hematological Malignancies in Phase I/II Study
2/15/2013
-
Stanford University Researchers Present Data on Highly Accurate Diagnostic Test for Preeclampsia in Development by Carmenta Bioscience
2/15/2013
-
Orion Corporation Release: Promising Preclinical and Phase I Data of a New Generation Androgen Receptor (AR) Inhibitor, ODM- 201, Presented at American Society of Clinical Oncology GU 2013 Symposium
2/15/2013
-
New Article in PLOS Currents: Evidence on Genomic Tests Supports Use of Veracyte, Inc.'s Afirma® Gene Expression Classifier to Resolve Ambiguous Thyroid Nodule Biopsies
2/15/2013
-
New Bioengineered Ears Look and Act Like the Real Thing, Weill Cornell Medical College Study
2/15/2013
-
MD Stem Cells Begins Intravitreal Stem Cell Treatments for Severe Visual Loss
2/15/2013
-
AlphaMed Release: New Study Shows Stem Cells' Promise as Future ALS Treatment
2/15/2013
-
International Stem Cell Corporation Strengthens Intellectual Property Portfolio
2/15/2013